🇺🇸 FDA
Patent

US 9382277

Pyrimido-pyridazinone compounds and methods of use thereof

granted A61KA61K31/519A61P

Quick answer

US patent 9382277 (Pyrimido-pyridazinone compounds and methods of use thereof) held by Asana BioSciences, LLC expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/519, A61P, A61P11/06, A61P17/00